arthyperАртериальная гипертензия"Arterial’naya Gipertenziya" ("Arterial Hypertension")1607-419X2411-8524Antihypertensive League10.18705/1607-419X-2025-2508BBVNGAarthyper-2508Research ArticleСтатьиArticlesФибромускулярная дисплазия почечных артерий. Состояние проблемыFibromuscular dysplasia of the renal arteries. Literature reviewhttps://orcid.org/0009-0009-3633-6845КогайС. В.KogayS. V.

Когай Сергей Валериевич — врач-кардиолог отделения сердечно-сосудистой хирургии № 2 Университетской клиники, ассистент кафедры факультетской терапии с клиникой лечебного факультета Института медицинского образования, ФГБУ «НМИЦ им. В.А. Алмазова» Минздрава России.

ул. Аккуратова, д. 2, Санкт-Петербург, 197341

Sergey V. Kogay - MD, Cardiologist, Department of Cardiovascular Surgery No. 2, Assistant, Department of Therapy with the Clinic, Medical Faculty, Institute of Medical Education, Almazov National Medical Research Center.

2 Akkuratov str., St Petersburg, 197341

Kogay_SV@almazovcentre.ruhttps://orcid.org/0000-0002-4392-5121АвдонинаН. Г.AvdoninaN. G.

Авдонина Наталья Георгиевна — научный сотрудник НИЛ патогенеза и терапии артериальной гипертензии НИО артериальной гипертензии Института сердца и сосудов, заведующая отделом информационного обеспечения и телемедицины Управления по реализации федеральных проектов, ФГБУ «НМИЦ им. В.А. Алмазова» Минздрава России.

Санкт-Петербург

Natalya G.Avdonina - MD, Researcher, Research Laboratory of Pathogenesis and Treatment of Hypertension, Research Department for Hypertension, Institute of Heart and Blood Vessels, Head, Department of Information Support and Telemedicine, Department for the Implementation of Federal Projects, Almazov National Medical Research Center.

St Petersburg

avdonina_ng@almazovcentre.ruhttps://orcid.org/0000-0001-5799-7778ПантелееваЮ. К.PanteleevaYu. K.

Пантелеева Юлия Константиновна — младший научный сотрудник научно-исследовательского отдела сосудистой и интервенционной хирургии, сердечно-сосудистый хирург отделения сердечно-сосудистой хирургии № 2 Университетской клиники ФГБУ «НМИЦ им. В.А. Алмазова» Минздрава России.

Санкт-Петербург

Yulia K. Panteleeva - MD, Junior Researcher, Research Institute of Vascular and Interventional Surgery, Cardiovascular Surgeon, Department of Cardiovascular Surgery No. 2, Almazov National Research Center.

St Petersburg

ybel96@bk.ruhttps://orcid.org/0000-0003-1214-0150ЧернявскийМ. A.ChernyavskyM. A.

Чернявский Михаил Александрович — доктор медицинских наук, заведующий научно-исследовательским отделом сосудистой и интервенционной хирургии, главный научный сотрудник, сердечно-сосудистый хирург отделения сердечно-сосудистой хирургии № 2 Университетской клиники, доцент кафедры факультетской хирургии с клиникой, ФГБУ «НМИЦ им. В.А. Алмазова» Минздрава России.

Санкт-Петербург

Mikhail A. Chernyavsky - MD, PhD, DSc, Head, Research Institute of Vascular and Interventional Surgery, Cardiovascular Surgeon, Associate Professor, Department of Specialized Surgery with the Clinic, Almazov National Medical Research Center.

St Petersburg

chernyavskiy_ma@almazovcentre.ruhttps://orcid.org/0000-0001-8169-7812КонрадиА. О.KonradiA. O.

Конради Александра Олеговна — доктор медицинских наук, профессор, академик РАН, заместитель генерального директора по научной работе, заведующая НИО артериальной гипертензии Института сердца и сосудов, заведующая кафедрой организации, управления и экономики здравоохранения факультета послевузовского и дополнительного образования Института медицинского образования, ФГБУ «НМИЦ им. В.А. Алмазова» Минздрава России.

Санкт-Петербург

Aleksandra O. Konradi - MD, PhD, DSc, Professor, Academician of the Russian Academy of Sciences, Deputy Director General for Scientific Work, Head, Department of Organization, Management and Economics of Healthcare, Faculty of Postgraduate and Additional Education, Institute of Medical Education, Almazov National Medical Research Center.

St Petersburg

konradi@almazovcentre.ruФедеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр имени В.А. Алмазова» Министерства здравоохранения Российской ФедерацииРоссияAlmazov National Medical Research CentreRussian Federation202505082025312115124Copyright © Когай С.В., Авдонина Н.Г., Пантелеева Ю.К., Чернявский М.A., Конради А.О., 20252025Когай С.В., Авдонина Н.Г., Пантелеева Ю.К., Чернявский М.A., Конради А.О.Kogay S.V., Avdonina N.G., Panteleeva Y.K., Chernyavsky M.A., Konradi A.O.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://htn.almazovcentre.ru/jour/article/view/2508

В настоящей статье рассмотрены основные вопросы, касающиеся выбора тактики лечения больных с фибромускулярной дисплазией почечных артерий. Продемонстрированы ключевые положения российских, европейских и американских согласительных документов. Уделено внимание последним исследованиям, отражающим современные представления об этиологии, факторах риска, генетических предикторах развития заболевания, а также хирургических подходах в лечении.

This article discusses the main issues related to the choice of tactics for the treatment of patients with fibromuscular dysplasia of the renal arteries. The key messages of the Russian, European and American consensus papers are presented. The current concepts of the etiology, risk factors, genetic predictors, as well as management approaches, including surgical treatment, are highlighted.

фибромускулярная дисплазия почечных артерийреноваскулярная артериальная гипертензияэндоваскулярная хирургиявторичная артериальная гипертензияfibromuscular dysplasia of the renal arteriesrenovascular arterial hypertensionendovascular surgerysecondary arterial hypertensionРабота поддержана ФГБУ НМИЦ им. В.А. Алмазова Минздрава России.The work was supported by the Almazov National Medical Research Center.ReferencesGornik HL, Persu A, Adlam D, Aparicio LS, Azizi M, Boulanger M, et al. First International Consensus on the diagnosis and management of fibromuscular dysplasia. Vasc Med. 2019;24(2):164–189. https://doi.org/10.1177/1358863X18821816Gornik HL, Persu A, Adlam D, Aparicio LS, Azizi M, Boulanger M, et al. First International Consensus on the diagnosis and management of fibromuscular dysplasia. Vasc Med. 2019;24(2):164–189. https://doi.org/10.1177/1358863X18821816Гришкевич А. А., Ревишвили А. Ш., Зотиков А. Е., Покровский А. В., Адырхаев З. А., Алекян Б. Г. и др. Хирургия почечных сосудов. М.: Фонд «Русские витязи», 2021. 300 с.Grishkevich AA, Revishvili ASh, Zotikov AE, Pokrovskii AV, Adyrkhaev ZA, Alekyan BG, et al. Renal Vascular Surgery. M.: Fund ‘Russian Knights’, 2021. 300 p. (In Russ.)Plouin PF, Baguet JP, Thony F, Ormezzano O, Azarine A, Silhol F, et al. High prevalence of multiple arterial bed lesions in patients with fibromuscular dysplasia: The ARCADIA Registry (Assessment of Renal and Cervical Artery Dysplasia). Hypertension. 2017;70(3):652–58. https://doi.org/10.1161/HYPERTENSIONAHA.117.09539Plouin PF, Baguet JP, Thony F, Ormezzano O, Azarine A, Silhol F, et al. High prevalence of multiple arterial bed lesions in patients with fibromuscular dysplasia: The ARCADIA Registry (Assessment of Renal and Cervical Artery Dysplasia). Hypertension. 2017;70(3):652–58. https://doi.org/10.1161/HYPERTENSIONAHA.117.09539Olin JW, Froehlich J, Gu X, Bacharach JM, Eagle K, Gray BH, et al. The United States Registry for fibromuscular dysplasia: results in the first 447 patients. Circulation. 2012;125(25): 3182–90. https://doi.org/10.1161/CIRCULATIONAHA.112.091223Olin JW, Froehlich J, Gu X, Bacharach JM, Eagle K, Gray BH, et al. The United States Registry for fibromuscular dysplasia: results in the first 447 patients. Circulation. 2012;125(25): 3182–90. https://doi.org/10.1161/CIRCULATIONAHA.112.091223Pappaccogli M, Di Monaco S, Warchoł-Celińska E, Lorthioir A, Amar L, Aparicio LS, et al. The European/International Fibromuscular Dysplasia Registry and Initiative (FEIRI)-clinical phenotypes and their predictors based on a cohort of 1000 patients. Cardiovasc Res. 2021;117(3):950–959. https://doi.org/10.1093/cvr/cvaa102Pappaccogli M, Di Monaco S, Warchoł-Celińska E, Lorthioir A, Amar L, Aparicio LS, et al. The European/International Fibromuscular Dysplasia Registry and Initiative (FEIRI)-clinical phenotypes and their predictors based on a cohort of 1000 patients. Cardiovasc Res. 2021;117(3):950–959. https://doi.org/10.1093/cvr/cvaa102Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104. https://doi.org/10.1093/eurheartj/ehy339Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104. https://doi.org/10.1093/eurheartj/ehy339Lenz T. Behandlung der Nierenarterienstenose im Jahr 2021. [Treatment of renal artery stenosis in the year 2021]. Internist (Berl). 2021;62(3):252–62. https://doi.org/10.1007/s00108-020-00935-5Lenz T. Behandlung der Nierenarterienstenose im Jahr 2021. [Treatment of renal artery stenosis in the year 2021]. Internist (Berl). 2021;62(3):252–62. https://doi.org/10.1007/s00108-020-00935-5Идрисов И. А., Хафизов Т. Н., Хафизов Р. Р., Шаймуратов И. Х., Абхаликова Е. Е., Идрисова Л. Р. Стеноз почечных артерий. Диагностика и тактика лечения пациентов (обзор литературы). Креативная хирургия и онкология. 2021;11(3):235–243. https://doi.org/10.24060/2076-3093-2021-11-3-235-243.Idrisov IA, Khafizov TN, Khafizov RR, Shaymuratov IKh, Abhalikova EE, Idrisova LR. Renal artery stenosis, diagnosis and management: a literature review. creative surgery and oncology. 2021;11(3):235–243. (In Russ.) https://doi.org/10.24060/2076-3093-2021-11-3-235-243Rana MN, Al-Kindi SG. Prevalence and manifestations of diagnosed fibromuscular dysplasia by sex and race: analysis of > 4500 FMD cases in the United States. Heart Lung. 2021;50(1):168–173. https://doi.org/10.1016/j.hrtlng.2020.09.022Rana MN, Al-Kindi SG. Prevalence and manifestations of diagnosed fibromuscular dysplasia by sex and race: analysis of > 4500 FMD cases in the United States. Heart Lung. 2021;50(1):168–173. https://doi.org/10.1016/j.hrtlng.2020.09.022Persu A, Van der Niepen P, Touzé E, Gevaert S, Berra E, Mace P, et al. Revisiting fibromuscular dysplasia: rationale of the european fibromuscular dysplasia initiative. Hypertension. 2016;68(4):832–9.Persu A, Van der Niepen P, Touzé E, Gevaert S, Berra E, Mace P, et al. Revisiting fibromuscular dysplasia: rationale of the european fibromuscular dysplasia initiative. Hypertension. 2016;68(4):832–9.Чазова И. Е., Чихладзе Н. М., Блинова Н. В., Белая Ж. Е., Данилов Н. М., Елфимова Е. М. и др. Евразийские клинические рекомендации по диагностике и лечению вторичных (симптоматических) форм артериальной гипертонии (2022). Евразийский Кардиологический Журнал. 2023;(1):6–65. https://doi.org/10.38109/2225-1685-2023-1-6-65Chazova IE, Chikhladze NM, Blinova NV, Belaya ZE, Danilov NM, Elfimova EM, et al. Eurasian clinical guidelines for the diagnosis and treatment of secondary (symptomatic) forms of arterial hypertension (2022). Eurasian Heart Journal. 2023;(1):6–65. (In Russ.) https://doi.org/10.38109/2225-1685-2023-1-6-65Щелкова Г. В., Данилов Н. М., Эркенова А. М., Яровой С. Ю., Матчин Ю. Г., Миронова О. Ю. и др. Консенсус по диагностике и лечению реноваскулярной артериальной гипертонии. Системные гипертензии. 2023;20(2):5–20. https://doi.org/10.38109/2075-082X-2023-2-5-20Shchelkova GV, Danilov NM, Erkenova AM, Yarovoy SYu, Matchin YuG, Mironova OYu, et al. Consensus on renovascular hypertension: diagnosis and treatment. Systemic Hypertension. 2023;20(2):5–20. (In Russ.) https://doi.org/10.38109/2075-082X-2023-2-5-20Baradhi KM, Bream P. Fibromuscular dysplasia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021Baradhi KM, Bream P. Fibromuscular dysplasia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021Shivapour DM, Erwin P, Kim ESh. Epidemiology of fibromuscular dysplasia: A review of the literature. Vasc Med. 2016;21(4):376–81. https://doi.org/10.1177/1358863X16637913Shivapour DM, Erwin P, Kim ESh. Epidemiology of fibromuscular dysplasia: A review of the literature. Vasc Med. 2016;21(4):376–81. https://doi.org/10.1177/1358863X16637913Wu HHL, Damle A, Chinnadurai R, Chrysochou C. Lessons for the clinical nephrologist: fibromuscular dysplasia in older adults. J Nephrol. 2025;38(1):283–288. https://doi.org/10.1007/s40620-024-02039-xWu HHL, Damle A, Chinnadurai R, Chrysochou C. Lessons for the clinical nephrologist: fibromuscular dysplasia in older adults. J Nephrol. 2025;38(1):283–288. https://doi.org/10.1007/s40620-024-02039-xLeadbetter WF, Burkland CE. Hypertension in unilateral renal disease. J Urol. 1938;39:611–26. https://doi.org/10.1016/S0022-5347(17)71895-2Leadbetter WF, Burkland CE. Hypertension in unilateral renal disease. J Urol. 1938;39:611–26. https://doi.org/10.1016/S0022-5347(17)71895-2McCormack LJ, Hazard JB, Poutasse EF. Obstructive lesions of the renal artery associated with remediable hypertension. Am J Pathol.1958;34:582.McCormack LJ, Hazard JB, Poutasse EF. Obstructive lesions of the renal artery associated with remediable hypertension. Am J Pathol.1958;34:582.Harrison EG, Jr McCormack LJ. Pathologic classification of renal arterial disease in renovascular hypertension. Mayo Clin Proc. 1971;46:161–7.Harrison EG, Jr McCormack LJ. Pathologic classification of renal arterial disease in renovascular hypertension. Mayo Clin Proc. 1971;46:161–7.Chrysant SG, Chrysant GS. Treatment of hypertension in patients with renal artery stenosis due to fibromuscular dysplasia of the renal arteries. Cardiovasc Diagn Ther. 2014;4(1):36–43. https://doi.org/10.3978/j.issn.2223-3652.2014.02.01Chrysant SG, Chrysant GS. Treatment of hypertension in patients with renal artery stenosis due to fibromuscular dysplasia of the renal arteries. Cardiovasc Diagn Ther. 2014;4(1):36–43. https://doi.org/10.3978/j.issn.2223-3652.2014.02.01Akiba Y, Endo A, Suzuki K, Hoshino Y, Suzuki T, Fujii Y. Fibromuscular dysplasia of coronary and brachial artery. Can J Cardiol. 2018;34(12):1689.e3–1689.e4. https://doi.org/10.1016/j.cjca.2018.09.002Akiba Y, Endo A, Suzuki K, Hoshino Y, Suzuki T, Fujii Y. Fibromuscular dysplasia of coronary and brachial artery. Can J Cardiol. 2018;34(12):1689.e3–1689.e4. https://doi.org/10.1016/j.cjca.2018.09.002Babapoor-Farrokhran S, Port Z. Fibromuscular dysplasia involving the coronary arteries. Methodist Debakey Cardiovasc J. 2021;17(1):71–72. https://doi.org/10.14797/OYIY5154Babapoor-Farrokhran S, Port Z. Fibromuscular dysplasia involving the coronary arteries. Methodist Debakey Cardiovasc J. 2021;17(1):71–72. https://doi.org/10.14797/OYIY5154Ko M, Kamimura K, Sakamaki A, Niwa Y, Tominaga K, Mizuno K, et al. Rare mesenteric arterial diseases: fibromuscular dysplasia and segmental arterial mediolysis and literature review. Intern Med. 2019;58(23):3393–3400. https://doi.org/10.2169/internalmedicine.3094-19Ko M, Kamimura K, Sakamaki A, Niwa Y, Tominaga K, Mizuno K, et al. Rare mesenteric arterial diseases: fibromuscular dysplasia and segmental arterial mediolysis and literature review. Intern Med. 2019;58(23):3393–3400. https://doi.org/10.2169/internalmedicine.3094-19Okazaki J, Guntani A, Homma K, Kyuragi R, Kawakubo E, Maehara Y. Fibromuscular dysplasia of the lower extremities. Ann Vasc Dis. 2011;4(2):143–9. https://doi.org/10.3400/avd.cr.10.01027Okazaki J, Guntani A, Homma K, Kyuragi R, Kawakubo E, Maehara Y. Fibromuscular dysplasia of the lower extremities. Ann Vasc Dis. 2011;4(2):143–9. https://doi.org/10.3400/avd.cr.10.01027Antonescu I, Knowles M, Wirtz E, Pascarella L.An unusual case of bilateral upper extremity ischemia caused by forearm vessel fibromuscular dysplasia. Ann Vasc Surg. 2019;56:353.e7–353.e11. https://doi.org/doi.org/10.1016/j.avsg.2018.08.110Antonescu I, Knowles M, Wirtz E, Pascarella L.An unusual case of bilateral upper extremity ischemia caused by forearm vessel fibromuscular dysplasia. Ann Vasc Surg. 2019;56:353.e7–353.e11. https://doi.org/doi.org/10.1016/j.avsg.2018.08.110Plouin PF, Perdu J, La Batide-Alanore A, Boutouyrie P, Gimenez-Roqueplo AP, Jeunemaitre X. Fibromuscular dysplasia. Orphanet J Rare Dis. 2007;2:28. https://doi.org/10.1186/1750-1172-2-28Plouin PF, Perdu J, La Batide-Alanore A, Boutouyrie P, Gimenez-Roqueplo AP, Jeunemaitre X. Fibromuscular dysplasia. Orphanet J Rare Dis. 2007;2:28. https://doi.org/10.1186/1750-1172-2-28Gladstien K, Rushton AR, Kidd KK. Penetrance estimates and recurrence risks for fibromuscular dysplasia. Clin Genet. 1980;17(2):115–6. https://doi.org/10.1111/j.1399-0004.1980.tb00117.xGladstien K, Rushton AR, Kidd KK. Penetrance estimates and recurrence risks for fibromuscular dysplasia. Clin Genet. 1980;17(2):115–6. https://doi.org/10.1111/j.1399-0004.1980.tb00117.xGanesh SK, Morissette R, Xu Z, Schoenhoff F, Griswold BF, Yang J, et al. Clinical and biochemical profiles suggest fibromuscular dysplasia is a systemic disease with altered TGF-β expression and connective tissue features. FASEB J. 2014;28:3313– 3324. https://doi.org/10.1096/fj.14-251207Ganesh SK, Morissette R, Xu Z, Schoenhoff F, Griswold BF, Yang J, et al. Clinical and biochemical profiles suggest fibromuscular dysplasia is a systemic disease with altered TGF-β expression and connective tissue features. FASEB J. 2014;28:3313– 3324. https://doi.org/10.1096/fj.14-251207Kiando SR, Tucker NR, Castro-Vega LJ, Katz A, D’Escamard V, Tréard C, et al. PHACTR1 is a genetic susceptibility locus for fibromuscular dysplasia supporting its complex genetic pattern of inheritance. PLoS Genet. 2016;12(10): e1006367. https://doi.org/10.1371/journal.pgen.1006367Kiando SR, Tucker NR, Castro-Vega LJ, Katz A, D’Escamard V, Tréard C, et al. PHACTR1 is a genetic susceptibility locus for fibromuscular dysplasia supporting its complex genetic pattern of inheritance. PLoS Genet. 2016;12(10): e1006367. https://doi.org/10.1371/journal.pgen.1006367Shimabukuro M. A new plausible link between lysophosphatidylcholine, TGF-β, and fibromuscular dysplasia. J Atheroscler Thromb. 2016;23(6):665–7. https://doi.org/10.5551/jat.ED040Shimabukuro M. A new plausible link between lysophosphatidylcholine, TGF-β, and fibromuscular dysplasia. J Atheroscler Thromb. 2016;23(6):665–7. https://doi.org/10.5551/jat.ED040Petropoulos T, Shah A, Dueck A, Hawkes C, Tobe SW, Kingston W, et al. Fibromuscular dysplasia: a focused review for the cardiologist. CJC Open. 2024;6(11):1274–1288. https://doi.org/10.1016/j.cjco.2024.07.014Petropoulos T, Shah A, Dueck A, Hawkes C, Tobe SW, Kingston W, et al. Fibromuscular dysplasia: a focused review for the cardiologist. CJC Open. 2024;6(11):1274–1288. https://doi.org/10.1016/j.cjco.2024.07.014Sharma AM, Kline B. The United States registry for fibromuscular dysplasia: new findings and breaking myths. Tech Vasc Interv Radiol. 2014;17(4):258–63. https://doi.org/10.1053/j.tvir.2014.11.007Sharma AM, Kline B. The United States registry for fibromuscular dysplasia: new findings and breaking myths. Tech Vasc Interv Radiol. 2014;17(4):258–63. https://doi.org/10.1053/j.tvir.2014.11.007Kadian-Dodov D, Gornik HL, Gu X, Froehlich J, Bacharach JM, Chi YW, et al. Dissection and aneurysm in patients with fibromuscular dysplasia: findings from the U. S. Registry for FMD. J Am Coll Cardiol. 2016;68(2):176–85. https://doi.org/10.1016/j.jacc.2016.04.044Kadian-Dodov D, Gornik HL, Gu X, Froehlich J, Bacharach JM, Chi YW, et al. Dissection and aneurysm in patients with fibromuscular dysplasia: findings from the U. S. Registry for FMD. J Am Coll Cardiol. 2016;68(2):176–85. https://doi.org/10.1016/j.jacc.2016.04.044Bloch MJ, Basile J. Clinical insights into the diagnosis and management of renovascular disease. An evidence-based review. Minerva Med. 2004;95(5):357–73Bloch MJ, Basile J. Clinical insights into the diagnosis and management of renovascular disease. An evidence-based review. Minerva Med. 2004;95(5):357–73O’Connor S, Gornik HL, Froehlich JB, Gu X, Gray BH, Mace PD, et al. Smoking and adverse outcomes in fibromuscular dysplasia: U. S. Registry report. J Am Coll Cardiol. 2016;67(14): 1750–1. https://doi.org/10.1016/j.jacc.2016.01.058O’Connor S, Gornik HL, Froehlich JB, Gu X, Gray BH, Mace PD, et al. Smoking and adverse outcomes in fibromuscular dysplasia: U. S. Registry report. J Am Coll Cardiol. 2016;67(14): 1750–1. https://doi.org/10.1016/j.jacc.2016.01.058Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71: e13-e115. https://doi.org/10.1161/HYP.0000000000000065Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71: e13-e115. https://doi.org/10.1161/HYP.0000000000000065Zeller T. Renal artery stenosis: epidemiology, clinical manifestation, and percutaneous endovascular therapy. J Interv Cardiol. 2005;18(6):497–506. https://doi.org/10.1111/j.1540–8183.2005.00092.xZeller T. Renal artery stenosis: epidemiology, clinical manifestation, and percutaneous endovascular therapy. J Interv Cardiol. 2005;18(6):497–506. https://doi.org/10.1111/j.1540–8183.2005.00092.xWarchol-Celinska E, Prejbisz A, Dobrowolski P, Klisiewicz A, Kadziela J, Florczak E, et al. Systematic and multidisciplinary evaluation of fibromuscular dysplasia patients reveals high prevalence of previously undetected fibromuscular dysplasia lesions and affects clinical decisions: the ARCADIA-POL study. Hypertension. 2020;75(4):1102–1109. https://doi.org/10.1161/HYPERTENSIONAHA.119.13239Warchol-Celinska E, Prejbisz A, Dobrowolski P, Klisiewicz A, Kadziela J, Florczak E, et al. Systematic and multidisciplinary evaluation of fibromuscular dysplasia patients reveals high prevalence of previously undetected fibromuscular dysplasia lesions and affects clinical decisions: the ARCADIA-POL study. Hypertension. 2020;75(4):1102–1109. https://doi.org/10.1161/HYPERTENSIONAHA.119.13239Wang LC, Scott DJ, Clemens MS, Hislop SJ, Arthurs ZM. Mechanism of stent failure in a patient with fibromuscular dysplasia following renal artery stenting. Ann Vasc Surg. 2015;29(1):123. e19–21. https://doi.org/10.1016/j.avsg.2014.08.002Wang LC, Scott DJ, Clemens MS, Hislop SJ, Arthurs ZM. Mechanism of stent failure in a patient with fibromuscular dysplasia following renal artery stenting. Ann Vasc Surg. 2015;29(1):123. e19–21. https://doi.org/10.1016/j.avsg.2014.08.002Kądziela J, Jóźwik-Plebanek K, Pappaccogli M, van der Niepen P, Prejbisz A, Dobrowolski P, et al. Risks and benefits of renal artery stenting in fibromuscular dysplasia: lessons from the ARCADIA-POL study. Vasc Med. 2024;29(1):50–57. https://doi.org/10.1177/1358863X231210523Kądziela J, Jóźwik-Plebanek K, Pappaccogli M, van der Niepen P, Prejbisz A, Dobrowolski P, et al. Risks and benefits of renal artery stenting in fibromuscular dysplasia: lessons from the ARCADIA-POL study. Vasc Med. 2024;29(1):50–57. https://doi.org/10.1177/1358863X231210523Cadour F, Silhol F, Iline N, Giorgi R, Lorthioir A, Amar L, et al. Insights from intravascular pressure measurement of renal artery revascularization in patients with fibromuscular dysplasia: The DYSART study. J Vasc Surg. 2022;75(3):939–49. e1. https://doi.org/10.1016/j.jvs.2021.09.023Cadour F, Silhol F, Iline N, Giorgi R, Lorthioir A, Amar L, et al. Insights from intravascular pressure measurement of renal artery revascularization in patients with fibromuscular dysplasia: The DYSART study. J Vasc Surg. 2022;75(3):939–49. e1. https://doi.org/10.1016/j.jvs.2021.09.023Meuse MA, Turba UC, Sabri SS, Park AW, Saad WE, Angle JF, et al. Treatment of renal artery fibromuscular dysplasia. Tech Vasc Interv Radiol. 2010;13(2):126–33. https://doi.org/10.1053/j.tvir.2010.02.007Meuse MA, Turba UC, Sabri SS, Park AW, Saad WE, Angle JF, et al. Treatment of renal artery fibromuscular dysplasia. Tech Vasc Interv Radiol. 2010;13(2):126–33. https://doi.org/10.1053/j.tvir.2010.02.007Sciacca L, Ciocca RG, Eslami MH, Messina LM. Endovascular treatment of renal artery aneurysm secondary to fibromuscular dysplasia: a case report. Ann Vasc Surg. 2009;23(4):536. e9–12. https://doi.org/10.1016/j.avsg.2008.11.011Sciacca L, Ciocca RG, Eslami MH, Messina LM. Endovascular treatment of renal artery aneurysm secondary to fibromuscular dysplasia: a case report. Ann Vasc Surg. 2009;23(4):536. e9–12. https://doi.org/10.1016/j.avsg.2008.11.011Яковлева Е. В., Волошинова Е. В., Тяпкина М. А., Махина В. И. Терапия. Эффективность баллонной ангиопластики в лечении фибромускулярной дисплазии почечных артерий (10-летнее наблюдение). Терапия. 2023;9(3):136–40. https://dx.doi.org/10.18565/therapy.2023.3.136–140Yakovleva EV, Voloshinova EV, Tyapkina MA, Makhina VI. Effectiveness of balloon angioplasty in the treatment of fibromuscular dysplasia of the renal arteries (10-year follow-up). Therapy. 2023;9(3):136–40. (In Russ.) https://dx.doi.org/10.18565/therapy.2023.3.136-140Itani HS, Mudawwar WA, Tanios BY, Alam SE, Haddad FF. First use of a drug-eluting balloon in the treatment of acute renal artery occlusion and in-stent restenosis. Am J Med Sci. 2013;346(3):244–6. https://doi.org/10.1097/MAJ.0b013e31828b2b7fItani HS, Mudawwar WA, Tanios BY, Alam SE, Haddad FF. First use of a drug-eluting balloon in the treatment of acute renal artery occlusion and in-stent restenosis. Am J Med Sci. 2013;346(3):244–6. https://doi.org/10.1097/MAJ.0b013e31828b2b7fHecht T, Esmaeili A, Behnke-Hall K. Balloon angioplasty of the bilateral renal arteries by Takayasu arteritis with a paclitaxeleluting balloon. Cardiol Young. 2015;25(7):1431–4. https://doi.org/10.1017/S1047951114001930Hecht T, Esmaeili A, Behnke-Hall K. Balloon angioplasty of the bilateral renal arteries by Takayasu arteritis with a paclitaxeleluting balloon. Cardiol Young. 2015;25(7):1431–4. https://doi.org/10.1017/S1047951114001930Li X, Zhang J, Meng Y, Yang L, Wang F, Li B, et al. Transplant renal artery stenosis caused by the stretch of an artery branch: a case report and literature review. BMC Nephrol. 2018;19(1):56. https://doi.org/10.1186/s12882-018-0856-yLi X, Zhang J, Meng Y, Yang L, Wang F, Li B, et al. Transplant renal artery stenosis caused by the stretch of an artery branch: a case report and literature review. BMC Nephrol. 2018;19(1):56. https://doi.org/10.1186/s12882-018-0856-yШукуров Ф. Б., Талиуридзе М. Т., Харлап М. С., Кардашова М. А., Федотова Н. П., Васильев Д. К. и др. Лечение фибромускулярной дисплазии почечной артерии посредством ангиопластики баллоном с лекарственным покрытием и внутрисосудистой визуализации: клинический случай. Российский кардиологический журнал. 2024;29(2S):5774. https://doi.org/10.15829/1560-4071-2024-5774Shukurov FB, Taliuridze MT, Kharlap MS, Kardashova MA, Fedotova NP, Vasiliev DK, et al. Treatment of renal artery fibromuscular dysplasia with drug-eluting balloon angioplasty and intravascular imaging: a case report. Russian Journal of Cardiology. 2024;29(2S):5774. (In Russ.) https://doi.org/10.15829/1560-4071-2024-5774Song X, Fu Y, Lai Z, Di X, Zeng R, Shao J, et al. Drug-coated balloon for treatment of non-atherosclerotic renal artery stenosis-a multi-center study. BMC Cardiovasc Disord. 2023;23(1):510. https://doi.org/10.1186/s12872-023-03484-5Song X, Fu Y, Lai Z, Di X, Zeng R, Shao J, et al. Drug-coated balloon for treatment of non-atherosclerotic renal artery stenosis-a multi-center study. BMC Cardiovasc Disord. 2023;23(1):510. https://doi.org/10.1186/s12872-023-03484-5Gavalas MV, Gasparis AP, Tassiopoulos AK, Loh S, Labropoulos N. Long-term follow-up for percutaneous transluminal angioplasty in renal artery fibromuscular dysplasia. Int Angiol. 2015;34(6):529–37.Gavalas MV, Gasparis AP, Tassiopoulos AK, Loh S, Labropoulos N. Long-term follow-up for percutaneous transluminal angioplasty in renal artery fibromuscular dysplasia. Int Angiol. 2015;34(6):529–37.Fujihara M, Fukata M, Higashimori A, Nakamura H, Odashiro K, Yokoi Y. Short- and mid-term results of balloon angioplasty for renal artery fibromuscular dysplasia. Cardiovasc Interv Ther. 2014;29(4):293–9. https://doi.org10.1007/s12928-014-0253-9Fujihara M, Fukata M, Higashimori A, Nakamura H, Odashiro K, Yokoi Y. Short- and mid-term results of balloon angioplasty for renal artery fibromuscular dysplasia. Cardiovasc Interv Ther. 2014;29(4):293–9. https://doi.org10.1007/s12928-014-0253-9Brekke IB, Sødal G, Jakobsen A, Bentdal O, Pfeffer P, Albrechtsen D, et al. Fibro-muscular renal artery disease treated by extracorporeal vascular reconstruction and renal autotransplantation: short- and long-term results. Eur J Vasc Surg. 1992;6(5):471–6. https://doi.org/10.1016/s0950-821x(05)80619-xBrekke IB, Sødal G, Jakobsen A, Bentdal O, Pfeffer P, Albrechtsen D, et al. Fibro-muscular renal artery disease treated by extracorporeal vascular reconstruction and renal autotransplantation: short- and long-term results. Eur J Vasc Surg. 1992;6(5):471–6. https://doi.org/10.1016/s0950-821x(05)80619-xGoodman J, Kulkarni S, Selvarajah V, Hilliard N, Russell N, Wilkinson IB. Renal autotransplantation for uncontrolled hypertension in nonatherosclerotic renal artery stenosis-2 case reports and a brief review of the literature. Hypertension. 2024;81(4):669– 675. https://doi.org/10.1161/HYPERTENSIONAHA.123.19878Goodman J, Kulkarni S, Selvarajah V, Hilliard N, Russell N, Wilkinson IB. Renal autotransplantation for uncontrolled hypertension in nonatherosclerotic renal artery stenosis-2 case reports and a brief review of the literature. Hypertension. 2024;81(4):669– 675. https://doi.org/10.1161/HYPERTENSIONAHA.123.19878

The authors declare that there are no conflicts of interest present.